Feasibility of a combination of high dose chemotherapy ifosfamide, carboplatin, etoposide (ICE) plus stem cells and bevacizumab in refractory sarcoma and germ cell tumors.

被引：0

作者：

Jordan, K ^{[1
]}

Kegel, T ^{[1
]}

Mueller, LP ^{[1
]}

Kinitz, I ^{[1
]}

Schmoll, HJ ^{[1
]}

机构：

[1] Univ Halle Wittenberg, Halle Saale, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：833S / 833S

页数：1

共 50 条

[21] Sequential high dose chemotherapy with paclitaxel and etoposide, carboplatin, melphalan and autologous stem cell support in patients with germ cell tumors; a phase II study
Koumakis, G.
Tryfonopoulos, D.
Vassilomanolakis, M.
Barbounis, V.
Res, E.
Demiri, S.
Tsoukalas, N.
Droufakou, S.
Filis, I.
Efremidis, A.
EJC SUPPLEMENTS, 2007, 5 (04): : 305 - 305
[22] SALVAGE CHEMOTHERAPY OF NONSEMINOMATOUS GERM-CELL TUMORS - PHASE-II TRIAL OF AN ETOPOSIDE, IFOSFAMIDE AND HIGH-DOSE CISPLATIN (VLHP) COMBINATION
RIBRAG, V
DROZ, JP
BOULEUC, C
THEODORE, C
GHOSN, M
PICO, JL
AZAB, M
OSTRONOFF, M
HAYAT, M
PRESSE MEDICALE, 1990, 19 (27): : 1263 - 1266
[23] A single institution experience: Paclitaxel/ifosfamide/cisplatin (TIP) chemotherapy in refractory or recurrent germ cell tumors.
Karagol, H
Derin, D
Yazar, A
Basaran, M
Bavbek, SE
Onat, H
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 439S - 439S
[24] Phase I/II Study of Paclitaxel Plus Ifosfamide Followed By High-Dose Paclitaxel, Ifosfamide, and Carboplatin with Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors
Feldman, Darren R.
Glezerman, Ilya
Patil, Sujata
Van Alstine, Lindsay
Bajorin, Dean F.
Fischer, Patricia
Hughes, Amanda
Sheinfeld, Joel
Bains, Manjit
Reich, Lilian
Bosl, George J.
Giralt, Sergio A.
Motzer, Robert J.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S90 - S90
[25] SURGICAL MANAGEMENT OF PATIENTS WITH ADVANCED GERM CELL TUMORS FOLLOWING SALVAGE CHEMOTHERAPY WITH PACLITAXEL, IFOSFAMIDE AND CISPLATIN (TIP) OR PACLITAXEL PLUS IFOSFAMIDE FOLLOWED BY HIGH DOSE CARBOPLATIN AND ETOPOSIDE WITH STEM CELL SUPPORT (TICE): MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC) EXPERIENCE
Imnadze, Mariam
Feldman, Darren
Carver, Brett
Bosl, George
Motzer, Robert
Bajorin, Dean
Sheinfeld, Joel
JOURNAL OF UROLOGY, 2015, 193 (04): : E110 - E110
[26] HIGH DOSE CARBOPLATIN, ETOPOSIDE, MELPHALAN AND AUTOLOGOUS HEMATOPOIETIC STEM CELL RESCUE WITH FOR THE TREATMENT OF RELAPSED PEDIATRIC GERM CELL TUMORS
Villela, N. C.
Gouveia, R., V
Macedo, C. R. D. P.
Zecchin, V. G.
Ginani, V. C.
Marconcini, J. F.
Felix, O. M. O.
Barros, D. P.
Alves, L. R.
Ibanez, A.
Simoes, P. C.
Silva, A. G.
Petrilli, A. S.
Seber, A.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S260 - S260
[27] HIGH-DOSE CARBOPLATIN VP-16 PLUS IFOSFAMIDE WITH AUTOLOGOUS BONE-MARROW SUPPORT IN THE TREATMENT OF REFRACTORY GERM-CELL TUMORS
BROUN, ER
NICHOLS, CR
TRICOT, G
LOEHRER, PJ
WILLIAMS, SD
EINHORN, LH
BONE MARROW TRANSPLANTATION, 1991, 7 (01) : 53 - 56
[28] IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN COMBINATION FOR INDUCTION AND HIGH-DOSE CHEMOTHERAPY - FOCUS ON BREAST-CANCER AND LYMPHOMA
FIELDS, KK
ELFENBEIN, GJ
SALEH, RA
ZORSKY, PE
JANSSEN, WE
PERKINS, JB
SALEH, TG
PIAZZA, JT
KRONISH, LE
MACHAK, MC
LYMAN, GH
HEMATOLOGICAL ONCOLOGY, 1992, 10 (01) : 61 - 74
[29] Phase I/II trial of high dose ifosfamide, carboplatin, and etoposide (ICE) at maximum tolerated dosage (MTD) with autologous stem cell rescue for refractory lymphoma.
Goldstein, S
Kronish, L
Ballester, O
Hiemenz, J
Sullivan, D
Saez, R
Sackstein, R
Partyka, J
Perkins, J
Janssen, W
Elfenbein, G
Fields, K
BLOOD, 1996, 88 (10) : 486 - 486
[30] HIGH-DOSE TREATMENT WITH CARBOPLATIN, ETOPOSIDE, AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY GERM-CELL CANCER - A PHASE I/II STUDY
SIEGERT, W
BEYER, J
STROHSCHEER, I
BAURMANN, H
OETTLE, H
ZINGSEM, J
ZIMMERMANN, R
BOKEMEYER, C
SCHMOLL, HJ
HUHN, D
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1223 - 1231

← 1 2 3 4 5 →